1,080 results on '"Pincus, T."'
Search Results
52. Most people over age 50 in the general population do not meet ACR remission criteria or OMERACT minimal disease activity criteria for rheumatoid arthritis
53. Work disability in early rheumatoid arthritis: higher rates but better clinical status in Finland compared with the US
54. Are American College of Rheumatology 50% response criteria superior to 20% criteria in distinguishing active aggressive treatment in rheumatoid arthritis clinical trials reported since 1997? A meta-analysis of discriminant capacities
55. Declines in number of tender and swollen joints in patients with rheumatoid arthritis seen in standard care in 1985 versus 2001: possible considerations for revision of inclusion criteria for clinical trials
56. Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count
57. Should aggressive therapy for rheumatoid arthritis require early use of weekly low-dose methotrexate, as the first disease-modifying anti-rheumatic drug in most patients?
58. Disparities in health according to socioeconomic status
59. Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities
60. How aggressive should initial therapy for rheumatoid arthritis be?
61. Should contemporary rheumatoid arthritis clinical trials be more like standard patient care and vice versa?
62. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis
63. Do rheumatology cost-effectiveness analyses make sense?
64. Understanding the process of care for musculoskeletal conditions—why a biomedical approach is inadequate
65. An Index of the Three Core Data Set Patient Questionnaire Measures Distinguishes Efficacy of Active Treatment From That of Placebo as Effectively as the American College of Rheumatology 20% Response Criteria (ACR20) or the Disease Activity Score (DAS) in a Rheumatoid Arthritis Clinical Trial
66. Third International Symposium for health professionals in rheumatology: Enschede 6–9 June 1990
67. Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review
68. RECALL BIAS, PAIN, DEPRESSION AND COST IN BACK PAIN PATIENTS
69. A SYSTEMATIC REVIEW OF PSYCHOLOGICAL FACTORS AS PREDICTORS OF CHRONICITY/DISABILITY IN PROSPECTIVE COHORTS OF LOW BACK PAIN
70. Usefulness of the HAQ in the clinic
71. A Randomized, Double-Blind, Crossover Clinical Trial of Diclofenac Plus Misoprostol Versus Acetaminophen in Patients With Osteoarthritis of the Hip or Knee
72. Eosinophilia-Myalgia Syndrome
73. Combination therapy for rheumatoid arthritis with methotrexate and cyclosporine
74. Disease burden in osteoarthritis (OA) is similar to rheumatoid arthritis (RA) from the patient’s perspective, slightly higher in ra at presentation, similar one year later, and slightly higher in oa two years later
75. Clues to recognition of secondary fibromyalgia in patients with osteoarthritis according to a fibromyalgia assessment screening tool of scales on a multidimensional health assessment questionnaire (MDHAQ/FAST3)
76. Osteoarthritis (OA) patients with low baseline pain, patient global and little morning stiffness are significantly more likely to improve over the next 6 months
77. Eosinophilia-Myalgia Syndrome : Status of Patients at Onset and after Four Years of Disease
78. Value of RAPID3 in patients with PsA: results from the TICOPA and LOPAS II databases
79. FRI0620 Low educational attainment is associated with poor patient status at the initial visit of patients with rheumatoid arthritis (RA) or osteoarthritis (OA) at the initial visit to a rheumatology setting, with similar patterns in patients with either diagnosis
80. FRI0678 Validity of three 0–10 visual analog scales (VAS) for quantitative physician assessment of inflammation, damage, and distress to supplement a physician global assessment 0–10 vas
81. FRI0549 Osteoarthritis (OA) and rheumatoid arthritis (RA) patients have similar disease burdens at first visit to an academic rheumatology setting, but oa patients have a higher burden at a 6-month follow-up visit
82. SAT0138 A delay to diagnosis, but not to treatment initiation, in patients with rheumatoid arthritis (RA) is associated with ethnic group at one us academic site
83. AB0313 Physician global assessment of the status of patients with rheumatoid arthritis (RA) at their first visit to an academic routine care setting are explained as much by damage and distress as by inflammation, according to physician ratings: should the structure of rheumatology care be modified?
84. THU0669 A self-report symptom checklist on a multidimensional health assessment questionnaire (MDHAQ) to capture a “positive review of systems” as a standard, quantitative, and informative “scientific” clue to fibromyalgia similar to modified criteria for fibromyalgia
85. THU0521 A simple index based on scores on a multidimensional health assessment questionnaire (MDHAQ) provides information quite similar to acr criteria for fibromyalgia in routine care
86. AB0312 Inflammatory activity appears well controlled in most patients with rheumatoid arthritis (RA) in contemporary rheumatology care, but joint damage and distress remain as problems of greater magnitude than inflammation
87. The patient perspective: is OA more debilitating than RA
88. Disease burden in rheumatology routine care setting is similar in osteoarthritis (OA) and rheumatoid arthritis (RA) at first visit but significantly greater in OA at a 6-month follow-up visit
89. The feasibility and acceptability of a physical activity intervention for older people with chronic musculoskeletal pain: The iPOPP pilot trial protocol
90. PATIENTS WITH RHEUMATOID ARTHRITIS CLASSIFIED AS "HIGH ACTIVITY" ACCORDING TO DAS28 OR CDAI INCLUDE 55% AND 70% WHO SCREEN POSITIVE FOR DEPRESSION AND 67% AND 80% WHO SCREEN POSITIVE FOR FIBROMYALGIA, RESPECTIVELY.
91. RHEUMETRIC QUANTITATIVE 0-10 PHYSICIAN ESTIMATES OF INFLAMMATION, DAMAGE, AND DISTRESS IN RHEUMATOID ARTHRITIS: VALIDATION AGAINST REFERENCE MEASURES.
92. INFLAMMATION IS MORE PROMINENT THAN JOINT DAMAGE AT INITIAL VISITS OF PATIENTS WITH INFLAMMATORY ARTHRITIDES, BUT ORGAN DAMAGE AND PATIENT DISTRESS ARE AS PROMINENT IN OVERALL RHEUMATOLOGY CARE: DATA FROM A FEASIBLE PHYSICIAN RHEUMATIC CHECKLIST.
93. AB1173 Physician visual analog scale estimates for overall global assessment, inflammation, damage, and distress to assess patients and support clinical decisions in routine rheumatology care: analysis of inter-rater reliability
94. SAT0069 A RAPID3-like index documents superior efficacy of BARICITINIB to ADALIMUMAB and placebo, similar to DAS28 and CDAI in the RA-BEAM clinical trial in patients with rheumatoid arthritis
95. SAT0109 Quantitative estimates of damage and distress, in addition to inflammation, and the proportion each of the 3 variables affects clinical management decisions (total=100%) may clarify assessment of clinical status in patients with rheumatoid arthritis (RA)
96. AB0232 Minimal clinically important improvement (MCII) of RAPID3 (routine assessment of patient index data 3), an index of only patient self-report scores, performs similarly to traditional rheumatoid arthritis (RA) indices, DAS28 and CDAI
97. THU0472 FAST3 (fibromyalgia assessment screening test): a composite index based on mdhaq provides clues to the presence of secondary fibromyalgia in patients with a primary diagnosis of rheumatoid arthritis at higher levels than identified in the medical record: a cross sectional study from routine care
98. AB0233 Remission according to RAPID3 (routine assessment of patient index data 3) in patients with rheumatoid arthritis: a cross-sectional study from routine care at 3 usa sites
99. AB1132 Higher rates of obesity and associations with poorer clinical status in patients with RA, OA and SLE: a cross-sectional study from routine care
100. AB0724 Higher likelihood of anti-tnf prescription in men vs women with ankylosing spondylitis despite similar disease burden: results from routine care at two academic rheumatology centers of usa and spain
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.